Abbott halts appeal, settles some preterm formula cases
The story in brief
Abbott has agreed to drop its appeal of a Missouri court's verdict upheld in May 2026, settling some preterm infant formula cases for $851.6 million. The company did not admit liability, maintaining confidence in its product safety. Over 1,700 lawsuits have been filed, with more than 825 federal cases consolidated in Chicago. Necrotising enterocolitis, a deadly condition in preterm infants, remains a focal point of the litigation.